These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3472024)

  • 21. [Serum level of the tumor marker CA 125 in ovarian pathology].
    Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
    Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of new three tumor markers for pancreatic carcinoma: CA19/9, CA 125 and DuPan 2].
    Ohkura H; Sakawaki T
    Gan No Rinsho; 1985 May; 31(6 Suppl):583-8. PubMed ID: 3861882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A new carbohydrate antigen CA 19-9 associated with malignancies of digestive system. I. Modification of its method and reference values].
    Sakurabayashi I; Kawai T; Yamanaka T; Kimura K; Yagisawa K; Igarashi S; Yonezawa M; Ioku A
    Rinsho Byori; 1984 May; 32(5):539-45. PubMed ID: 6592377
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contemporary molecular-biological methods of cancer diagnosis and monitoring based on the humoral immune response to tumor-associated antigens].
    Shebzukhov IuV; Belousov PV; Khlgatian SV; Sazykin AIu; Kuprash DV; Nedospasov SA
    Mol Gen Mikrobiol Virusol; 2007; (2):3-6. PubMed ID: 17600920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sialyl Lewis(a): a tumor-associated carbohydrate antigen involved in adhesion and metastatic potential of cancer cells.
    Ugorski M; Laskowska A
    Acta Biochim Pol; 2002; 49(2):303-11. PubMed ID: 12362971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
    Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
    Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562
    [No Abstract]   [Full Text] [Related]  

  • 28. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 29. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
    Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
    Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
    [No Abstract]   [Full Text] [Related]  

  • 30. [Tumor-associated antigens and their importance in tumor diagnosis].
    von Kleist S
    Verh Dtsch Ges Inn Med; 1980; 86():503-6. PubMed ID: 7223038
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thomsen antigen in human normal and tumor tissues].
    Berdinskikh MS; Pavliuchenkova RP; Kiseleva AS; Kulakova AM; Kosiakov PN
    Biull Eksp Biol Med; 1983 Mar; 95(3):59-61. PubMed ID: 6830988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tumor-associated markers as organ-specific antigens of human seminal plasma. I. Immunologic studies].
    Höller U; Uhlenbruck G; Dienst C; Dreessen C
    Z Hautkr; 1985 Jan; 60(1-2):147-56. PubMed ID: 3856977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
    Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
    Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.
    Zhang JY; Casiano CA; Peng XX; Koziol JA; Chan EK; Tan EM
    Cancer Epidemiol Biomarkers Prev; 2003 Feb; 12(2):136-43. PubMed ID: 12582023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Monoclonal anti-tumor antibodies and their clinical application].
    Taniguchi M
    Rinsho Byori; 1983 Dec; 31(12):1303-7. PubMed ID: 6202902
    [No Abstract]   [Full Text] [Related]  

  • 36. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in the study of antitumor vaccines with tumor-associated carbohydrate antigen].
    Di W; Wang L; Peng T; Wang SQ
    Yao Xue Xue Bao; 2005 Jul; 40(7):591-9. PubMed ID: 16196263
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum CA 19-9 and CA 50 antigens in hemodialysis patients.
    Docci D; Pistocchi E; Turci F; Baldrati L; Urbini S; Scaioli S
    Clin Nephrol; 1987 Apr; 27(4):179-81. PubMed ID: 3472698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood group antigens in tumor cell membranes.
    Coon JS; Weinstein RS
    Biomembranes; 1983; 11():173-205. PubMed ID: 6338946
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serial changes in serum CA 19-9 levels in pancreatic cancer].
    Saito K; Tajiri H; Yoshimori M; Hijikata A; Ohkura H; Nakamura K; Ozaki H
    Gan No Rinsho; 1987 Aug; 33(9):1057-60. PubMed ID: 3476762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.